drugset / Trial / NCT01361789

COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined

NCT01361789

Phase 4 Completed 93 enrolled Asker & Baerum Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Recent studies on molar surgery have shown that a combination of a glucocorticoid and NSAID or COX-2 selective inhibitor gives better pain relief than either of the drugs used separately. The investigators group has also shown that adding dexamethasone on top of a regimen of paracetamol, NSAID and local anesthesia resulted in 45% painfree patients at rest after ambulatory breast cancer surgery. The goal of this study is to test the NSAID + glucocorticoid concept in ACl repair. The investigators want to evaluate whether a selective COX-2 selective inhibitor or a glucocorticoid or a combination of both drugs, as part of a multimodal analgesic regime, can provide improved pain relief and shorter hospital stay in patients undergoing outpatient ACL surgery.

Timeline

Start
2004-01
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 8 mg Intravenous
Comparator Etoricoxib Small molecule 120 mg
Comparator Parecoxib Small molecule 40 mg
Comparator valdecoxib Small molecule 40 mg

Indications

No indication recorded.